Ivana Carey

2.4k total citations
65 papers, 1.3k citations indexed

About

Ivana Carey is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Ivana Carey has authored 65 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 52 papers in Hepatology and 7 papers in Infectious Diseases. Recurrent topics in Ivana Carey's work include Hepatitis C virus research (48 papers), Hepatitis B Virus Studies (44 papers) and Liver Disease Diagnosis and Treatment (32 papers). Ivana Carey is often cited by papers focused on Hepatitis C virus research (48 papers), Hepatitis B Virus Studies (44 papers) and Liver Disease Diagnosis and Treatment (32 papers). Ivana Carey collaborates with scholars based in United Kingdom, United States and Netherlands. Ivana Carey's co-authors include Kosh Agarwal, Geoffrey Dusheiko, Matthew Bruce, Phillip Harrison, Sheila Payne, Mike Nolan, Bo Wang, Michael A. Heneghan, Nigel Heaton and Andrew D. Yeoman and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

Ivana Carey

59 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ivana Carey	903	843	205	131	77	65	1.3k
Ponni Perumalswami	903 1.0×	861 1.0×	209 1.0×	61 0.5×	55 0.7×	86	1.2k
Montserrat Laguno	913 1.0×	802 1.0×	956 4.7×	84 0.6×	56 0.7×	92	1.8k
Fabrizio Giostra	634 0.7×	703 0.8×	84 0.4×	30 0.2×	128 1.7×	58	1.3k
Pablo Ryan	513 0.6×	341 0.4×	478 2.3×	29 0.2×	68 0.9×	104	1.1k
Dorota Zarębska‐Michaluk	382 0.4×	350 0.4×	535 2.6×	33 0.3×	95 1.2×	123	1.1k
Pamela K. Green	1.6k 1.8×	1.6k 1.9×	106 0.5×	52 0.4×	61 0.8×	29	2.0k
Valerianna Amorosa	346 0.4×	332 0.4×	375 1.8×	40 0.3×	51 0.7×	36	888
Russell Rosenblatt	397 0.4×	382 0.5×	61 0.3×	77 0.6×	57 0.7×	73	725
Naresh Bansal	477 0.5×	359 0.4×	455 2.2×	16 0.1×	134 1.7×	71	1.1k
Julius Wilder	347 0.4×	341 0.4×	54 0.3×	146 1.1×	73 0.9×	43	728

Countries citing papers authored by Ivana Carey

Since Specialization

Citations

This map shows the geographic impact of Ivana Carey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivana Carey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivana Carey more than expected).

Fields of papers citing papers by Ivana Carey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivana Carey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivana Carey. The network helps show where Ivana Carey may publish in the future.

Co-authorship network of co-authors of Ivana Carey

This figure shows the co-authorship network connecting the top 25 collaborators of Ivana Carey. A scholar is included among the top collaborators of Ivana Carey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivana Carey. Ivana Carey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lok, James, James Michael Harris, Ivana Carey, Kosh Agarwal, & Jane A. McKeating. (2025). Assessing the virological response to direct-acting antiviral therapies in the HBV cure programme. Virology. 605. 110458–110458. 1 indexed citations

Buti, Marı́a, Özgür M. Koc, Kosh Agarwal, et al.. (2023). Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe. Journal of Hepatology. 80(2). 243–250. 8 indexed citations

Carey, Ivana, Mark Anderson, James Lok, et al.. (2023). P130 Role of HDV genotype in HDV RNA positive patients – impact on disease progression and response to therapy with pegylated interferon. Poster presentations. A100–A101.

Carey, Ivana, et al.. (2022). Universal versus targeted screening for HCV infection in pregnancy in a diverse, multi‐ethnic population: Universal screening is more comprehensive. Journal of Viral Hepatitis. 29(12). 1079–1088. 5 indexed citations

Ajaz, Saima, Mark McPhail, Luigi Gnudi, et al.. (2020). Mitochondrial dysfunction as a mechanistic biomarker in patients with non-alcoholic fatty liver disease (NAFLD). Mitochondrion. 57. 119–130. 58 indexed citations

Galloway, James, Sam Norton, Richard D. Barker, et al.. (2020). A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study. Journal of Infection. 81(2). 282–288. 127 indexed citations

Spaan, Michelle, Ivana Carey, Matthew Bruce, et al.. (2020). Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1. Journal of Hepatology. 72(6). 1097–1104. 47 indexed citations

Carey, Ivana, Jeffrey Gersch, Bo Wang, et al.. (2019). Pregenomic HBV RNA and Hepatitis B Core‐Related Antigen Predict Outcomes in Hepatitis B e Antigen–Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy. Hepatology. 72(1). 42–57. 115 indexed citations

Carey, Ivana, M. Horner, Matthew Bruce, et al.. (2018). Serum NGAL can act as an early renal safety biomarker during long‐term nucleos(t)ide analogue antiviral therapy in chronic hepatitis B. Journal of Viral Hepatitis. 25(10). 1139–1150. 2 indexed citations

10.

Wang, Bo, et al.. (2018). HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg‐positive patients treated with nucleos(t)ide analogues. Journal of Viral Hepatitis. 25(8). 886–893. 35 indexed citations

11.

Joshi, Deepak, Ivana Carey, & Kosh Agarwal. (2013). Review article: the treatment of genotype 1 chronic hepatitis C virus infection in liver transplant candidates and recipients. Alimentary Pharmacology & Therapeutics. 37(7). 659–671. 10 indexed citations

12.

Bruce, Matthew, M. Horner, Deepak Joshi, et al.. (2012). Strong decline in HBsAg levels after virological response in a large monocentric therapy cohort: potential to select HBeAg positive chronic hepatitis B patients for finite duration?. Hepatology. 56. 2 indexed citations

13.

Carey, Ivana, Matthew Bruce, Deepak Joshi, Diego Vergani, & Kosh Agarwal. (2012). PMO-158 RS12979860 CC genotype is associated with baseline high numbers of CD56bright NK-cells, low numbers of CD3-CD56-CD16+ cells, low IL-10 HCV-specific production in CH-C therapy responders. Gut. 61(Suppl 2). A137.3–A138.

14.

Shang, Dazhuang, Sarah Hughes, M. Horner, et al.. (2012). Development and validation of an efficient in-house real-time reverse transcription polymerase chain reaction assay for the quantitative detection of serum hepatitis delta virus RNA in a diverse South London population. Journal of Virological Methods. 184(1-2). 55–62. 19 indexed citations

15.

Sherwood, Roy, et al.. (2011). NO EFFECT OF TENOFOVIR OR ENTECAVIR ON VITAMIN D LEVELS IN CHRONIC HEPATITIS B MONO-INFECTED PATIENTS. SINGLE CENTRE 'REAL LIFE' COHORT EXPERIENCE. Hepatology. 54. 2 indexed citations

16.

Carey, Ivana, et al.. (2011). DE-NOVO ANTIVIRAL THERAPY WITH NUCLEOS(T)IDE ANALOGUES IN 'REAL-LIFE' PATIENTS WITH CHRONIC HEPATITIS B INFECTION: COMPARISON OF VIROLOGICAL RESPONSES BETWEEN LAMIVUDINE plus ADEFOVIR VS. ENTECAVIR VS. TENOFOVIR THERAPY. Hepatology. 54. 8 indexed citations

17.

Carey, Ivana, et al.. (2011). P47 De-novo antiviral therapy with nucleos(t)ide analogues in ‘real-life’ patients with chronic hepatitis B infection: comparison of virological responses between lamivudine + adefovir vs entecavir vs tenofovir therapy. Gut. 60(Suppl 2). A22.2–A23. 3 indexed citations

18.

Hughes, Sarah, Ivana Carey, Dazhuang Shang, et al.. (2009). HEPATITIS DELTA VIRUS RNA LEVEL AND IGM ANTIBODY TITER PREDICT RESPONSE TO PEG-INTERFERON THERAPY. Hepatology. 50(4). 2 indexed citations

19.

Carey, Ivana & Phillip Harrison. (2009). Monotherapy versus combination therapy for the treatment of chronic hepatitis B. Expert Opinion on Investigational Drugs. 18(11). 1655–1666. 32 indexed citations

20.

Yeoman, Andrew D., Rachel Westbrook, Ivana Carey, et al.. (2009). Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease†. Hepatology. 50(2). 538–545. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact